Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Diamyd Medical logo — Developing precision medicine therapies for Type 1 Diabetes

Diamyd Medical

Developing precision medicine therapies for Type 1 Diabetes

Founded 1994 Sweden Sweden 45 employees Post Ipo Equity Biotechnology

General Information

Company Name Diamyd Medical
Founded Year 1994
Location Sweden Sweden +1
Employees 45
Industries Biotechnology
Funding Stage Post Ipo Equity
Social

Get notified when Diamyd Medical moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Diamyd Medical

Diamyd Medical is a Swedish diabetes company developing precision medicine therapies for Type 1 Diabetes. The therapeutic diabetes vaccine Diamyd , an antigen-specific immunotherapy for the preservation of endogenous insulin production, is being evaluated in the ongoing Phase III trial DIAGNODE-3. The company is establishing a vaccine manufacturing facility in Umeå for the manufacture of recombinant GAD65, the active ingredient in the diabetes vaccine. Diamyd Medical also develops the GABA-based investigational drug Remygen® as a therapy for regeneration of endogenous insulin production and to improve hormonal response to hypoglycaemia. Diamyd Medical is one of the major shareholders in the stem cell company NextCell Pharma AB as well as in the artificial intelligence company MainlyAI AB. The Diamyd Medical share is traded on Nasdaq First North Growth Market, ticker DMYD B.

No funding data available for Diamyd Medical yet.

Get notified when Diamyd Medical raises funding

Diamyd Medical Alternatives & Competitors

Diamyd Medical vs
Hedia
Hedia Denmark

Our vision is to improve quality of life for people with diabetes and make the best diabetes managem...

Seed
43 employees
AI, Life Sciences
Compare Diamyd Medical vs Hedia
Diamyd Medical vs
Capillary Biomedical
Capillary Biomedical United States

Capillary Biomedical, Inc. (CapBio) is a medical device startup developing technologies for diabetes...

Debt Financing
10 employees
Biotechnology, Health Care
Compare Diamyd Medical vs Capillary Biomedical
Diamyd Medical vs
Valeritas
Valeritas United States

Improving health and simplifying life for people with diabetes.

Series Unknown
35 employees
Biotechnology, Health Care
Compare Diamyd Medical vs Valeritas

FAQ About Diamyd Medical

Developing precision medicine therapies for Type 1 Diabetes
Diamyd Medical was founded in 1994.
Diamyd Medical is headquartered in Sweden.
Diamyd Medical operates in the following industries: Biotechnology.
Diamyd Medical has approximately 45 employees.
Top alternatives and competitors to Diamyd Medical include Hedia, Capillary Biomedical, Valeritas, IBD Medical, DreaMed Diabetes. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Diamyd Medical and Hedia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Diamyd Medical and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes